Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 bzw. § 130c Abs. 1 des Fünften
DAK-Gesundheit awarded €1 to Almirall Hermal GmbH for Healthcare & Medical in January 2024 — one of 389 awards this buyer has made, in line with its typical award size.
Buying agency
DAK-GesundheitWinning supplier
Almirall Hermal GmbHContract description
Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 bzw. § 130c Abs. 1 des Fünften Sozialgesetzbuchs - Ebglyss (Wirkstoff: Lebrikizumab), ATC D11AH10
Related awards · DAK-Gesundheit
389 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-210283-2024Aktivital GmbH€9.1M10 Apr 2024 Healthcare
- ocds-ted-211590-2024Kraaibeek GmbH€2.5M10 Apr 2024 Healthcare
- ocds-ted-828775-2025news aktuell GmbH€38.0K12 Dec 2025 IT
Other wins · Almirall Hermal GmbH
24 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-142340-2026-1PBMG eGNot disclosed02 Mar 2026 Healthcare
- ocds-ted-142340-2026-2PBMG eGNot disclosed02 Mar 2026 Healthcare
- ocds-ted-142340-2026-3PBMG eGNot disclosed02 Mar 2026 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for DAK-Gesundheit and Almirall Hermal GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back